版本:
中国

BRIEF-Glaukos completes patient enrollment in phase ii clinical trial for idose™ travoprost intraocular implant

May 3 Glaukos Corp:

* Glaukos completes patient enrollment in phase ii clinical trial for idose™ travoprost intraocular implant in glaucoma patients

* Glaukos corp- topline readout expected later in 2017 for study Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐